Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Pi Therapeutics logo — Pioneering new therapies targeting the ubiquitin-proteasome...

Pi Therapeutics

Pioneering new therapies targeting the ubiquitin-proteasome system to combat cancer.

Founded 2015 Series B Total: $19.70M Biotechnology

General Information

Company Name Pi Therapeutics
Founded Year 2015
Industries Biotechnology
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Pi Therapeutics. To contact Pi Therapeutics, visit pi-tx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pi Therapeutics compare?

A PDF of Pi Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pi Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pi Therapeutics

Pi Therapeutics is a biopharmaceutical company dedicated to pioneering new therapies targeting the ubiquitin-proteasome system (UPS) to combat cancer. Since March 2015, the company has been operational within the FutuRx biotech accelerator located in Ness Ziona, Israel. The latest significant financial backing came in the form of a $19.70M Series B investment at 29 May 2019, with key investors including Pontifax, GHS Fund, RMGP, GF Securities, CBG Asset Management, and Arkin Bio Ventures. Notable backers of the company include Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, and the Israel Innovation Authority. Pi Therapeutics is focused on discovering and developing innovative cancer treatments by creating new first-in-class drugs targeting the UPS for cancer treatment.

Business keywords: biopharmaceutical company, cancer treatments, drug discovery, Ubiquitin-proteasome system, cancer therapy, Takeda Pharmaceuticals, Johnson & Johnson Innovation, OrbiMed Israel Partners, Pontifax, Israel Innovation Authority, FutuRx biotech accelerator, Israel, oncology, venture capital, startups

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $19.70M 6
Pontifax GHS Fund RMGP
Pontifax, GHS Fund +4
29 May 2019

Pi Therapeutics Alternatives & Competitors

View All Alternatives
Pi Therapeutics vs
OnCusp Therapeutics
OnCusp Therapeutics United States

We Bring Oncology Innovation to Life

Series A
28 employees
Biotechnology, Health Care
Pi Therapeutics vs
Nurix Therapeutics
Nurix Therapeutics United States

Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outma...

IPO
378 employees
Biotechnology
Pi Therapeutics vs
EVIIVE AG
EVIIVE AG Switzerland

Unleash the full potential of liquid biopsies for the earliest disease prevention and personalized t...

Seed
2 employees
Biotechnology
View all alternatives

FAQ About Pi Therapeutics

Pioneering new therapies targeting the ubiquitin-proteasome system to combat cancer.
Pi Therapeutics was founded in 2015.
Pi Therapeutics operates in Biotechnology. Its work centres on biopharmaceutical company, cancer treatments, drug discovery and Ubiquitin-proteasome system.
Pi Therapeutics has completed 1 funding round, raising a total of $19.70M. The latest funding stage is Series B.
Top alternatives and competitors to Pi Therapeutics include OnCusp Therapeutics, Nurix Therapeutics, EVIIVE AG, Day One Biopharmaceuticals, Nexo Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pi Therapeutics and OnCusp Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pi Therapeutics, https://bouncewatch.com/company/pi-therapeutics, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout